☆ 4.8 Article

Predicting response to immunotherapy in gastric cancer via multi-dimensional analyses of the tumour immune microenvironment

NATURE COMMUNICATIONS (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Computer Science, Artificial Intelligence

Fast and Accurate Least-Mean-Squares Solvers for High Dimensional Data

Alaa Maalouf et al.

Summary: This article introduces a new algorithm that can compute subsets with positive weights in a short amount of time, which is crucial for solving machine learning problems and matrix factorizations. The algorithm combines data summarization techniques like sketches and coresets, providing performance boost for existing LMS solvers.

IEEE TRANSACTIONS ON PATTERN ANALYSIS AND MACHINE INTELLIGENCE (2022)

添加到收藏夹

Article Oncology

Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial

Carlotta Antoniotti et al.

Summary: The addition of atezolizumab to first-line FOLFOXIRI plus bevacizumab is safe and improves progression-free survival in previously untreated metastatic colorectal cancer patients.

LANCET ONCOLOGY (2022)

添加到收藏夹

Review Immunology

Neutrophils in cancer: heterogeneous and multifaceted

Catherine C. Hedrick et al.

Summary: Neutrophils have emerged as important regulators of cancer, revealing their diverse and plastic contributions in tumor development and growth, influencing positively and negatively depending on time, place, and disease context. Their functional importance in cancer has been overlooked due to their short-lived, terminally differentiated, and non-proliferative characteristics, but recent studies have led to a paradigm shift in understanding their roles.

NATURE REVIEWS IMMUNOLOGY (2022)

添加到收藏夹

Article Hematology

Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma

Matias Autio et al.

Summary: The study characterized the immunological profile of DLBCL TME using Nanostring platform and multiplex immunohistochemistry, revealing high heterogeneity at the transcriptome level. A high proportion of immune checkpoint positive T cells in the tumor microenvironment was associated with unfavorable survival outcomes.

HAEMATOLOGICA (2021)

添加到收藏夹

Article Oncology

Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer

Sara A. Vayrynen et al.

Summary: The study revealed a diverse set of myeloid cells within the PDAC tumor microenvironment, which are distributed heterogeneously across patient tumors. Beyond cell density, the spatial locations of immune cells are also associated with patient outcomes, underscoring the potential role of spatially resolved myeloid cell subtypes as quantitative biomarkers for PDAC prognosis and therapy.

CLINICAL CANCER RESEARCH (2021)

添加到收藏夹

Article Oncology

Current treatment and recent progress in gastric cancer

Smita S. Joshi et al.

Summary: Gastric cancer is a common cause of cancer death worldwide, with treatment options including systemic chemotherapy, radiotherapy, surgery, immunotherapy, and targeted therapy. Classification and biomarkers for gastric cancer help in personalized therapy and identifying populations most likely to benefit from immunotherapy and targeted therapy.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Article Oncology

First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811

Hyun Cheol Chung et al.

Summary: Current treatment options for patients with HER2-positive advanced gastric cancer are limited, with poor prognosis. Pembrolizumab in combination with trastuzumab and chemotherapy may provide a benefit for these patients.

FUTURE ONCOLOGY (2021)

添加到收藏夹

Review Oncology

Paradigms on Immunotherapy Combinations with Chemotherapy

Diego Salas-Benito et al.

Summary: Checkpoint inhibitors are being added to standard-of-care chemotherapy in clinical trials with success reported in various cancer types, but chemotherapy regimens have not been optimized for these combinations; optimal approaches to chemo-immunotherapy should include neoadjuvant and adjuvant schemes to maximize the benefits of both treatments.

CANCER DISCOVERY (2021)

添加到收藏夹

Article Oncology

High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types

D. J. McGrail et al.

Summary: Analysis of over 10,000 patient tumors from The Cancer Genome Atlas showed that TMB-H tumors had significantly higher response rates to immune checkpoint blockade in certain cancer types, while showing no significant benefit in others. These results do not support the use of TMB-H as a biomarker for ICB treatment across all solid cancer types, indicating the need for further tumor type-specific studies.

ANNALS OF ONCOLOGY (2021)

添加到收藏夹

Editorial Material Oncology

Putting the Microenvironment into the Immunotherapy Companion Diagnostic

Myrto Moutafi et al.

Summary: Based on a post hoc analysis in advanced gastric cancer, PD-L1 showed a stronger association with immunotherapy efficacy when measured by combined positive score (CPS) compared to tumor cells (TC%). This suggests that expression of immune cells in the tumor microenvironment can enhance the value of companion diagnostic tests.

CLINICAL CANCER RESEARCH (2021)

添加到收藏夹

Article Oncology

Dose escalation and expansion (phase Ia/Ib) study of GLS-010, a recombinant fully human antiprogrammed death-1 monoclonal antibody for advanced solid tumors or lymphoma

Dan Liu et al.

Summary: GLS-010 demonstrated acceptable safety profile and favorable clinical response in patients with lymphoma and solid tumors, with a recommended dose of 240 mg Q2W.

EUROPEAN JOURNAL OF CANCER (2021)

添加到收藏夹

Article Oncology

Prognostic significance of myeloid immune cells and their spatial distribution in the colorectal cancer microenvironment

Juha P. Vayrynen et al.

Summary: Myeloid cell populations in the colorectal cancer microenvironment exhibit spatially distinct distributions and subset-specific prognostic significance. Mature CD14(+)HLA-DR+ and immature CD14(+)HLA-DR- monocytic phenotypes show opposite associations. These findings underscore the prognostic utility of multimarker evaluation of myeloid cell infiltrates and reveal a previously unrecognized degree of spatial organization for myeloid cells in the immune microenvironment.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

添加到收藏夹

Article Oncology

Subcutaneous envafolimab monotherapy in patients with advanced defective mismatch repair/microsatellite instability high solid tumors

Jian Li et al.

Summary: Envafolimab demonstrated significant efficacy and acceptable safety in the treatment of previously treated advanced dMMR/MSI-H solid tumors. The objective response rate was 42.7%, disease control rate was 66.0%, and median progression-free survival was 11.1 months.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial

Yelena Y. Janjigian et al.

Summary: Nivolumab plus chemotherapy showed superior overall survival and progression-free survival compared to chemotherapy alone in previously untreated patients with advanced gastric, gastro-oesophageal junction, or oesophageal adenocarcinoma, indicating it as a new standard first-line treatment option with acceptable safety profile.

LANCET (2021)

添加到收藏夹

Article Oncology

STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer

Seung Joon Lee et al.

Summary: STING activation can normalize the peritoneal vascular and immune microenvironment, converting immunologically cold peritoneal tumors into T-cell-inflamed tumors and providing a rationale for a novel combination therapeutic strategy for peritoneal carcinomatosis in colon cancer.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

添加到收藏夹

Article Oncology

Soluble immune checkpoints and T-cell subsets in blood as biomarkers for resistance to immunotherapy in melanoma patients

Devayani Machiraju et al.

Summary: Different mechanisms lead to resistance to immune checkpoint inhibitors in melanoma patients. Soluble immune checkpoints and T cell expression were analyzed, showing associations between certain markers and resistance to specific treatments, with potential implications for clinical use.

ONCOIMMUNOLOGY (2021)

添加到收藏夹

Article Oncology

Prognostic and Predictive Value of Microsatellite Instability, Inflammatory Reaction and PD-L1 in Gastric Cancer Patients Treated with Either Adjuvant 5-FU/LV or Sequential FOLFIRI Followed by Cisplatin and Docetaxel: A Translational Analysis from the ITACA-S Trial

Maria Di Bartolomeo et al.

ONCOLOGIST (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Tertiary lymphoid structures improve immunotherapy and survival in melanoma

Rita Cabrita et al.

NATURE (2020)

添加到收藏夹

Article Oncology

First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial

Yelena Y. Janjigian et al.

LANCET ONCOLOGY (2020)

添加到收藏夹

Article Immunology

PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer

Brian Diskin et al.

NATURE IMMUNOLOGY (2020)

添加到收藏夹

Article Oncology

Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial

Kohei Shitara et al.

JAMA ONCOLOGY (2020)

添加到收藏夹

Article Oncology

Smoking Status at Diagnosis and Colorectal Cancer Prognosis According to Tumor Lymphocytic Reaction

Kenji Fujiyoshi et al.

JNCI CANCER SPECTRUM (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Y Targeting the STING pathway in tumor-associated macrophages regulates innate immune sensing of gastric cancer cells

Lei Miao et al.

THERANOSTICS (2020)

添加到收藏夹

Letter Gastroenterology & Hepatology

Response to: 'Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma'

Sascha Rahn et al.

GUT (2019)

添加到收藏夹

Article Oncology

Hyperprogression after immunotherapy in patients with malignant tumors of digestive system

Zhi Ji et al.

BMC CANCER (2019)

添加到收藏夹

Article Oncology

Differences in immune contextures among different molecular subtypes of gastric cancer and their prognostic impact

Joo Yeon Kim et al.

GASTRIC CANCER (2019)

添加到收藏夹

Article Clinical Neurology

Association between plasma GFAP concentrations and MRI abnormalities in patients with CT-negative traumatic brain injury in the TRACK-TBI cohort: a prospective multicentre study

John K. Yue et al.

LANCET NEUROLOGY (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Macrophage spatial heterogeneity in gastric cancer defined by multiplex immunohistochemistry

Yu-Kuan Huang et al.

NATURE COMMUNICATIONS (2019)

添加到收藏夹

Article Oncology

irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical Trial

Jean-Christophe Pignon et al.

CLINICAL CANCER RESEARCH (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer

Chao Lin et al.

GUT (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer

Seung Tae Kim et al.

NATURE MEDICINE (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging

Leeat Keren et al.

CELL (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Association Between Expression Level of PD1 by Tumor-Infiltrating CD8+ T Cells and Features of Hepatocellular Carcinoma

Hyung-Don Kim et al.

GASTROENTEROLOGY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma

Elizabeth D. Thompson et al.

GUT (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway

Ting-ting Wang et al.

GUT (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer

Julienne L. Carstens et al.

NATURE COMMUNICATIONS (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing

Chunhong Zheng et al.

CELL (2017)

添加到收藏夹

Article Medicine, General & Internal

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

Yung-Jue Bang et al.

LANCET (2010)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.